FDA Inspection 1054871 — Divyam Institute Of Psychiatry
The FDA completed an inspection of Divyam Institute Of Psychiatry on May 11, 2018 in Palsana. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 11, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Palsana (India)
Additional Details
In Vivo Bioequivalence